Literature DB >> 35978697

Application of Degradation of Cyclic-AMP Response Element Binding Protein for the Potential Treatment of Cancer.

Robert B Kargbo1.   

Abstract

Entities:  

Year:  2022        PMID： 35978697      PMCID： PMC9377326          DOI： 10.1021/acsmedchemlett.2c00317

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.632


× No keyword cloud information.
  6 in total

Review 1.  cAMP-PKA cascade: An outdated topic for depression?

Authors:  Feng Gao; Shaojie Yang; Juan Wang; Guoqi Zhu
Journal:  Biomed Pharmacother       Date:  2022-04-26       Impact factor: 6.529

Review 2.  Therapeutic potential of phosphodiesterase inhibitors for cognitive amelioration in Alzheimer's disease.

Authors:  Meiyang Xi; Tianyu Sun; Shejie Chai; Mengjiao Xie; Siqi Chen; Liping Deng; Kui Du; Runpu Shen; Haopeng Sun
Journal:  Eur J Med Chem       Date:  2022-02-03       Impact factor: 6.514

Review 3.  Astrocytic Calcium and cAMP in Neurodegenerative Diseases.

Authors:  Marta Sobolczyk; Tomasz Boczek
Journal:  Front Cell Neurosci       Date:  2022-05-19       Impact factor: 6.147

Review 4.  Next steps for clinical translation of adenosine pathway inhibition in cancer immunotherapy.

Authors:  Ryan C Augustin; Robert D Leone; Aung Naing; Lawrence Fong; Riyue Bao; Jason J Luke
Journal:  J Immunother Cancer       Date:  2022-02       Impact factor: 13.751

Review 5.  Clinical considerations for the design of PROTACs in cancer.

Authors:  Cristina Nieto-Jiménez; Esther Cabañas Morafraile; Carlos Alonso-Moreno; Alberto Ocaña
Journal:  Mol Cancer       Date:  2022-03-07       Impact factor: 27.401

Review 6.  PROTAC targeted protein degraders: the past is prologue.

Authors:  Miklós Békés; David R Langley; Craig M Crews
Journal:  Nat Rev Drug Discov       Date:  2022-01-18       Impact factor: 112.288
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.